What is azilsartan medoxomil used for?
Azilsartan is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Azilsartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily.
What is the brand name for azilsartan?
Azilsartan medoxomil is marketed under the brand name Edarbi. It is used to treat hypertension as monotherapy or in combination with other antihypertensive drugs. It is also available in a combination product with chlorthalidone.
Is azilsartan better than telmisartan?
Using clinic monitoring and ABPM, the present study found that AZL-M has greater antihypertensive efficacy than telmisartan, with comparable side effects. This suggests that AZL-M may enhance BP control in patients with hypertension. In addition, AZL-M was found to elicit a better response rate compared to telmisartan.
What drug class is azilsartan?
Azilsartan is in a class of medications called angiotensin II receptor antagonists. It works by blocking the action of certain natural substances that tighten the blood vessels, allowing the blood to flow more smoothly and the heart to pump more efficiently.
What are the side effects of azilsartan medoxomil?
Common side effects of Edarbi include:
- dizziness on standing,
- weakness/lack of energy, and.
- tired feeling.
Does azilsartan affect kidney function?
This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure.
Who manufactures Edarbyclor?
EDARBI (azilsartan medoxomil) is an angiotensin II receptor blocker (ARB) developed by Takeda for the treatment of hypertension to lower blood pressure in adults. EDARBI lowers blood pressure by blocking the action of angiotensin II, a vasopressor hormone, which naturally exists within the body.
Is Azilsartan and telmisartan same?
Azilsartan a new Angiotensin receptor blocker has shown superior BP lowering effects when compared with Telmisartan and is well tolerated in patients with Hypertension on the basis of this data we could expect that Azilsartan leads to enhanced BP control in patients with stage I and stage II Hypertension.
When was azilsartan FDA approved?
Approval Date: 2/25/2011.
What is a good substitute for Edarbyclor?
Avapro (irbesartan) and Edarbi (azilsartan medoxomil) are angiotensin II receptor blockers (ARBs) used to treat high blood pressure (hypertension). Avapro is sometimes given together with other blood pressure medications.
Is medoxomil a salt?
Figure 1 shows the chemical structure of azilsartan kamedoxomil, the potassium salt used in the product formulation of azilsartan medoxomil. This salt is practically insoluble in water and is freely soluble in methanol.
What is the retail price of Edarbyclor?
Edarbyclor is covered by some Medicare and insurance plans. The lowest GoodRx price for the most common version of Edarbyclor is around $218.83, 16% off the average retail price of $262.06. Compare ARB / thiazide-like diuretic combinations.
Is there a generic version of Edarbyclor?
Edarbyclor (azilsartan/chlorthalidone) is a combination of an angiotensin II receptor blocker (ARB) and a diuretic. It is used to treat high blood pressure. This drug is more popular than comparable drugs. There are currently no generic alternatives to Edarbyclor.
Is telmisartan still on the market?
Telmisartan is available in 20, 40 and 80 mg tablets in generic forms and under the trade name, Micardis. The typical dose of Telmisartan in adults is 40 to 80 mg once daily, and it is used long term. Telmisartan is also available in fixed combinations with hydrochlorothiazide, and amlodipine.
What is the most effective ARB for hypertension?
- Losartan (Cozaar) was the first ARB to ever be approved, so it has the longest track record of success.
- Losartan is available as a very affordable generic.
- Losartan is made as a stand-alone drug, and in a combination tablet with the diuretic, hydrochlorothiazide (HCTZ), as losartan/HCTZ. Convenient.
Who is the manufacturer of EDARBI?
EDARBI (azilsartan medoxomil) is an angiotensin II receptor blocker (ARB) developed by Takeda for the treatment of hypertension to lower blood pressure in adults.
How long has Edarbyclor been on the market?
The FDA approved Edarbyclor in December 2011 for the treatment of hypertension in patients whose blood pressure has not been adequately controlled with 1 medication or as an initial therapy for patients who are likely to need multiple drugs. It is available in 40/12.5-mg and 40/25-mg fixed-dose combinations.